Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-05-30

FDA Approved: NITROFURANTOIN — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for nitrofurantoin from Rising Pharma Holdings, Inc. The action likely updates labeling or indications for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (Nitrofurantoin)

Snippet

SUPPL AP for NITROFURANTOIN (NITROFURANTOIN)